We are live on
!
Find out more
CCA
Catalyst Capital Advisors Portfolio holdings
AUM
$6.03B
1-Year Est. Return
24.5%
This Fund
S&P 500
This Quarter
Est. Return
+2.73%
1 Year Est. Return
+24.5%
3 Year Est. Return
+62.66%
5 Year Est. Return
+62.45%
10 Year Est. Return
+241.55%
AUM
$872M
AUM Growth
+$19.8M
(+2.3%)
Cap. Flow
+$16.5M
Cap. Flow
% of AUM
1.89%
Top 10 Holdings %
Top 10 Hldgs %
18.4%
Holding
619
New
128
Increased
115
Reduced
79
Closed
181
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$20.3M |
| 2 |
Delta Air Lines
DAL
|
+$16.9M |
| 3 |
S
Sprint Corporation
S
|
+$15.9M |
| 4 |
Enovis
ENOV
|
+$14.7M |
| 5 |
SWN
Southwestern Energy Company
SWN
|
+$13.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bausch Health
BHC
|
+$21.7M |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$19.8M |
| 3 |
Flex
FLEX
|
+$17.9M |
| 4 |
Synchrony
SYF
|
+$15.3M |
| 5 |
Boston Scientific
BSX
|
+$14.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.85% |
| 2 | Industrials | 13.14% |
| 3 | Consumer Discretionary | 12.72% |
| 4 | Technology | 12.14% |
| 5 | Energy | 10.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VRTV
101
DELISTED
VERITIV CORPORATION
VRTV
| $2.29M | 0.26% |
52,000
+39,500
| +316% | +$1.97M |
|
|
ECOM
102
DELISTED
CHANNELADVISOR CORPORATION
ECOM
| $2.23M | 0.26% |
+230,000
| New | +$2.55M |
|
103
Beazer Homes USA
BZH
$907M
| $2.17M | 0.25% |
+122,500
| New | +$2.09M |
|
104
Globalstar
GSAT
$10.2B
| $2.17M | 0.25% |
43,333
-66,667
| -61% | -$2.75M |
|
105
Rayonier Advanced Materials
RYAM
$565M
| $2.09M | 0.24% |
+140,000
| New | +$2.55M |
|
106
Wendy's
WEN
$1.33B
| $2.07M | 0.24% |
189,600
-29,200
| -13% | -$312K |
|
|
FCSC
107
DELISTED
Fibrocell Science Inc.
FCSC
| $1.98M | 0.23% |
29,280
-1,333
| -4% | -$85.9K |
|
|
BRSS
108
DELISTED
Global Brass & Copper Hldgs, Inc
BRSS
| $1.97M | 0.23% |
127,500
+30,000
| +31% | +$416K |
|
|
AEGN
109
DELISTED
Aegion Corp
AEGN
| $1.9M | 0.22% |
105,000
| – | – |
|
|
AFFX
110
DELISTED
Affymetrix Inc
AFFX
| $1.88M | 0.22% |
+150,000
| New | +$1.74M |
|
111
Advanced Drainage Systems
WMS
$10.9B
| $1.8M | 0.21% |
+60,000
| New | +$1.56M |
|
112
Sanofi
SNY
$104B
| $1.77M | 0.2% |
35,900
| – | – |
|
113
Ball Corp
BALL
$17B
| $1.77M | 0.2% |
50,000
| – | – |
|
|
HCR
114
DELISTED
Hi-Crush Inc. Common Stock
HCR
| $1.75M | 0.2% |
50,000
+30,000
| +150% | +$1.05M |
|
|
FRM
115
DELISTED
FURMANITE CORPORATION COM
FRM
| $1.7M | 0.19% |
215,000
+50,000
| +30% | +$374K |
|
116
American Coastal Insurance
ACIC
$498M
| $1.63M | 0.19% |
72,500
-30,000
| -29% | -$716K |
|
117
Novartis
NVS
$295B
| $1.6M | 0.18% |
18,107
| – | – |
|
|
SSE
118
DELISTED
SEVENTY SEVEN ENERGY INC COM
SSE
| $1.6M | 0.18% |
385,000
| – | – |
|
|
ORAN
119
DELISTED
Orange
ORAN
| $1.53M | 0.18% |
95,500
| – | – |
|
120
Williams Companies
WMB
$90.5B
| $1.46M | 0.17% |
28,936
+6,408
| +28% | +$297K |
|
|
FGP
121
DELISTED
Ferrellgas Partners, L.P.
FGP
| $1.46M | 0.17% |
60,000
+10,000
| +20% | +$235K |
|
|
YHOO
122
DELISTED
Yahoo Inc
YHOO
| $1.44M | 0.16% |
+32,350
| New | +$1.46M |
|
|
PAY
123
DELISTED
Verifone Systems Inc
PAY
| $1.4M | 0.16% |
40,100
| – | – |
|
124
Campbell Soup
CPB
$6.51B
| $1.37M | 0.16% |
29,500
| – | – |
|
125
Comstock Resources
CRK
$3.97B
| $1.36M | 0.16% |
76,000
| – | – |
|
Similar funds
RCG
WHRC
EAM
AAM
CM
HPG
EMPI
GA
Catalyst Capital Advisors's Q1 2015 Portfolio in Review
As of Q1 2015, Catalyst Capital Advisors held 619 positions worth $872M, up 2.3% from $852M the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Catalyst Capital Advisors's Q1 2015 filing shows 128 new, 115 increased, 79 reduced and 181 closed positions. Its largest new stake was Alnylam Pharmaceuticals: 200,250 shares worth $20.9M. The largest sale was Bausch Health, an estimated $21.7M.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 15% a quarter earlier, followed by Industrials and Consumer Discretionary.
- Catalyst Capital Advisors's largest Q1 2015 buy was Alnylam Pharmaceuticals: 200,250 shares worth $20.9M.
- Catalyst Capital Advisors added most to Delta Air Lines in Q1 2015, an estimated $16.9M increase.
- Catalyst Capital Advisors's biggest Q1 2015 reduction was Bausch Health, cutting an estimated $21.7M.
- Catalyst Capital Advisors fully exited COVIDIEN PLC COM SHS NEW (IRELAND) in Q1 2015, selling an estimated $19.8M.
- Catalyst Capital Advisors's ten largest holdings make up 18% of its $872M portfolio in Q1 2015.
- Catalyst Capital Advisors opened 128 new positions and closed 181 in Q1 2015.
- Catalyst Capital Advisors's portfolio value rose 2.3% quarter-over-quarter to $872M.
Based on Catalyst Capital Advisors's 13F filing for Q1 2015, filed 15 May 2015.